Solvay Sells Drugs Unit to Abbott for $6.6B

September 27, 2009

195

Belgian drugs, chemicals and plastics maker Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.6 billion) in cash and reinvest in chemicals and plastics.

*For more on this story,

read the full Reuters

article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Weekly in-depth coverage in print and digital formats
Special Features: OC's Wealthiest, Top Priced Home Sales, Giving Guide, OC500, Charity Event Guide, Best Places to Work, Indispensables, Largest Charitable Gifts
The annual Book of Lists: Orange County's top companies across every industry

Brand Affinity Strikes Pact with CBS Billboard Unit

READER LETTERS

staff-author

Solvay Sells Drugs Unit to Abbott for $6.6B

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

On the Move: CAPATA Welcomes Manny M. Trelles, CPA, as a Partner

Photos: The Emerald Bay Home That Sold for a Record $110M

Inside KIngsbarn Realty Capital and Kelemen’s Terravita Project in Laguna Hills

Related Articles

On the Move: CAPATA Welcomes Manny M. Trelles, CPA, as a Partner

Photos: The Emerald Bay Home That Sold for a Record $110M

Inside KIngsbarn Realty Capital and Kelemen’s Terravita Project in Laguna Hills

OC Unemployment Falls to 3.5% in May

Midday Stock Roundup: Indie Semiconductor Shares Jump 8%, Trading at Double its Usual Volume

Advertise With Us

About Us

Subscriber Links

Other Journals